More Scalp Microneedling? A 245-Woman Minoxidil Trial

If you are offered extra microneedling visits alongside minoxidil, ask what evidence supports the added procedure for your hair-loss diagnosis. A 2026 trial in women provides a specific comparison worth taking to that conversation.

What the 245-woman trial compared

The randomized, open-label, single-center trial enrolled 245 women with mild-to-moderate androgenetic alopecia. It compared 2% topical minoxidil alone with the same treatment plus monthly microneedling or microneedling every two weeks. Follow-up lasted 24 weeks; 234 participants completed the study. [1]

The primary outcome was the change in nonvellus hair count in a target area. All groups improved, with no significant between-group differences. Other measured hair outcomes were also comparable. More frequent sessions did not demonstrate an added benefit under these study conditions. [1]

This does not establish that every device, schedule or hair-loss condition would give the same result. The abstract identifies the single-center, unblinded design and missing patient-reported outcomes as limitations. We reviewed the PubMed abstract and disclosure, not the full report. No conflicts were disclosed; funding was not reported in the abstract. [1]

Name the diagnosis before comparing packages

AAD describes diagnosis as the starting point for treatment. A dermatologist asks how long hair loss has been present and whether it developed quickly, examines the scalp and other affected areas, and may arrange tests when the history and examination suggest a particular cause. More than one cause can coexist. [2]

Bring a dated account of when you noticed shedding or thinning, your current medicines and the products or procedures you have tried. Include GLP-1 treatment in that medication history. Ask the clinician to explain which finding supports the diagnosis being treated.

The trial concerns androgenetic alopecia. Its abstract does not identify a GLP-1-treated subgroup or establish treatment effects for shedding during weight loss. It cannot demonstrate that adding microneedling prevents or reverses a change associated with your GLP-1 treatment. [1]

Read the claim beside the outcome

If a clinic cites this paper, ask for the sentence connecting its result to the service being offered. Keep three questions on your consultation note:

• What added improvement should the procedure provide over my proposed medicine plan?
• How will we assess the change I care about, and when?
• What would lead us to continue, change or stop the procedure?

Ask to see the complete charge for the proposed course, including reviews, and the cancellation terms. Take the written plan home if you need time to consider the appointment burden or cost. These are purchase and consultation questions, not a tested treatment protocol.

A study does not authorize a device for every use

In the United States, FDA lists specific authorized microneedling uses involving facial acne scars, facial wrinkles and abdominal scars in adults aged 22 or older. That list does not include scalp hair growth. FDA also says these devices are not approved to deliver topical medicines, cosmetics or blood products into skin. [3]

FDA advises discussing the practitioner's training, the benefits and risks, cleaning and use of a new needle cartridge for every patient and every session. Report your medical conditions and medicines before a procedure. Its patient guidance identifies concerns including bleeding disorders, immune suppression, uncontrolled diabetes and active skin infection. [3]

Request written aftercare and a contact for possible complications. Do not copy needle settings from a study or change when you apply minoxidil without the treating clinician's advice.

For background, see the scalp-microneedling consultation guide and hair-shedding preparation guide.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.